Revlimid and Imnovid Triple Combination for Multiple Myeloma Treatment Get EU Approval

in #pharma5 years ago

Celgene Corporation (CELG) got the European Commission approval of two of its triple regiments for multiple myeloma treatment.
The two oral medicines are used in combination with dexamethasone.
shutterstock_160000913-896x480.jpg
https://blog.genexi.ru/news/Revlimid-and-Imnovid-Triple-Combination-for-Multiple-Myeloma-Treatment-Get-EU-Approval-en

Coin Marketplace

STEEM 0.19
TRX 0.15
JST 0.029
BTC 63294.77
ETH 2638.69
USDT 1.00
SBD 2.70